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Globally the change towards the establishment of a bio-based economy has resulted
in an increased need for bio-based applications. This, in turn, has served as a
driving force for the discovery and application of novel biosurfactants. The class
Actinobacteria represents a vast group of microorganisms with the ability to produce
a diverse range of secondary metabolites, including surfactants. Understanding the
extensive nature of the biosurfactants produced by actinobacterial strains can assist
in finding novel biosurfactants with new potential applications. This review therefore
presents a comprehensive overview of the knowledge available on actinobacterial
surfactants, the chemical structures that have been completely or partly elucidated,
as well as the identity of the biosurfactant-producing strains. Producer strains of
not yet elucidated compounds are discussed, as well as the original habitats of
all the producer strains, which seems to indicate that biosurfactant production
is environmentally driven. Methodology applied in the isolation, purification and
structural elucidation of the different types of surface active compounds, as well as
surfactant activity tests, are also discussed. Overall, actinobacterial surfactants can
be summarized to include the dominantly occurring trehalose-comprising surfactants,
other non-trehalose containing glycolipids, lipopeptides and the more rare actinobacterial
surfactants. The lack of structural information on a large proportion of actinobacterial
surfactants should be considered as a driving force to further explore the abundance
and diversity of these compounds. This would allow for a better understanding
of actinobacterial surface active compounds and their potential for biotechnological
application.
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Microbial Surfactants and their Applications
Microbially derived compounds that share hydrophilic and hydrophobic moieties, and that
are surface active, are commonly referred to as biosurfactants. Many have been detected and
described, and the majorityare molecules of low molecular weight. Within this group of low
molecular weight microbial surfactants, the classes of lipopeptides or glycolipids, where fatty
acid or hydroxy fatty acid chains are linked to either peptides or carbohydrates, have been
extensively studied (Hausmann and Syldatk, 2014). The combinations of different types of
hydrophilic and hydrophobic moieties within surfactants are innumerable and highly biodiverse.
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Due to their amphiphillic structures, surfactants act as emulsify-
ing agents, resulting in low surface tensions of interphases. Often,
microorganisms produce them when growing on hydrophobic
carbon sources or when exposed to growth limiting conditions.
It is hypothesized, that biosurfactants play a role in the uptake
of various hydrophobic carbon sources thus making nutrients
bioavailable, as well as the protection of bacteria from harsh
environmental conditions (Ristau and Wagner, 1983; Vollbrecht
et al., 1998; Philp et al., 2002). Some biosurfactants show antimi-
crobial effects and the distinction of secondary metabolites as
antibiotics or biosurfactants is often not strict.
Biosurfactants, compared to chemically derived surfactants,
are independent of mineral oil as a feedstock, they are read-
ily biodegradable and can be produced at low temperatures.
Furthermore, they are described to be less toxic, effective at low
concentrations and show effects in bioremediation. Industrial
interest in biosurfactants is not solely based on the bio-acitivity of
these molecules, but is also due to the broader ecological aware-
ness linked to their application, which in turn is driven by sus-
tainability initiatives and green agendas (Marchant and Banat,
2012). Biosurfactants can be applied in various areas such as the
nutrient-, cosmetic-, textile-, varnish-, pharmaceutical-, mining-,
and oil recovery industries (Henkel et al., 2012; Marchant and
Banat, 2012; Müller et al., 2012).
An example of an actinobacterial biosurfactant that has
already entered the market and found industrial application, is
the lipopeptide antibiotic daptomycin. This antibiotic is used in
the treatment of diseases caused by Gram positive pathogens
and has been marketed as Cubicin R© by Cubist Pharmaceuticals.
FIGURE 1 | Systematic classification of the class Actinobacteria
including subclasses and orders. Suborder, families and genera
examined for the production of biosurfactants and bioemulsifying
compounds are displayed in numbers. Thirty six surfactant-producing
genera are reported, all belonging to the largest order within the
Actinobacteria: Actinomycetales.
Other promising studies for the potential application of acti-
nobacterial biosurfactants are in environmental applications such
as bioremediation: Oil spills were successfully dispersed by bio-
surfactants produced by a Gordonia sp. (Saeki et al., 2009), a
Dietzia sp. (Wang et al., 2014) and a Rhodococcus sp. (Kuyukina
and Ivshina, 2010); and trehalose lipids were applied in micro-
bial enhanced oil recovery and the cleaning of oil storage tanks
(Franzetti et al., 2010). In medical applications, the production
of biosurfactants are generally considered safer than synthetically
produced compounds due to high enzymatic precision during
synthesis. Antiproliferation activities of cancerogenic cells could
be induced by application of various glycolipids (Isoda et al.,
1997; Sudo et al., 2000). In cosmetic applications, the use of tre-
halose lipids is favored above that of sodium dodecyl sulfate as it
causes less irritation (Marques et al., 2009).
Different types of biosurfactants or bioemulsifiers have been
described to be produced as secondary metabolites within the
class Actinobacteria, and to the best of our knowledge, all
of the producing species belong to the order Actinomycetales
(Figure 1). The following section of the review will focus on
the different types of actinobacterial biosurfactants reported in
literature as well as their key structural features and bio-activities.
Metabolite Production within the Class
Actinobacteria
Over the past few decades, there has been an increased interest
in the discovery of bioactive metabolites with novel bioactive
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properties and their potential for application in medical- or
industrial-based processes. Microbial products are still consid-
ered to be the most promising source for the discovery of novel
chemicals or therapeutic agents (Berdy, 2005). In addition, vast
microbial genetic resources remains untapped and can lead to the
development of novel bioactive metabolites.
In contrast to primary metabolites, secondary metabolites
often accumulate and have miscellaneous chemical composi-
tions that are species-specific. These secondary metabolites often
exhibit bioactivity and are therefore of great interest to vari-
ous industries. The most dominant source of microbially derived
bioactive compounds is a group of bacteria known to have rela-
tively large genomes and constitutes one of the main phyla within
the Prokaryotes: The class Actinobacteria (Ludwig and Klenk,
2001). The class Actinobacteria play important roles in the envi-
ronment, e.g., nutrient cycling, but also include major plant, ani-
mal and human pathogens (Embley and Stackebrandt, 1994), well
known examples are the causative agents of leprosy and tuber-
culosis. Baltz (2008) assumed 5–10% of their genome coding
capacity to be used for the production of secondary metabo-
lites and indeed more than 35% of all known bioactive micro-
bial metabolites and more than 63% of all known prokaryotic
bioactive metabolites arise from actinobacteria (Bérdy, 2012).
Most secondary metabolite producers described belong to fam-
ilies of the Actinomycetales, but it is estimated that only ∼1% of
them are culturable (Bérdy, 2012). Many of these actinobacterial
secondary metabolites exhibit antibacterial, antifungal, antitu-
mor, anticancer and/or cytotoxic properties (Manivasagan et al.,
2013). Antibiotics, with around 10,000 compounds described
(Bérdy, 2012) is by far the largest group of metabolites isolated
from actinobacteria. Depending on their chemical nature, the
huge number of antibiotic compounds can roughly be classi-
fied into peptides, aminoglycosides, polyketides, alkaloids, fatty
acids, and terpenes (Manivasagan et al., 2013; Abdelmohsen
et al., 2014). Besides antibiotics, other actinobacterial compounds
described are bioactive compounds with pharmacological activity
(pheromones, toxins, enzyme inhibitors, receptors and immuno-
logical modulators), with agricultural activity (pesticides, herbi-
cides and insecticides) and other industrially relevant properties
(pigments and surfactants). Most compounds are derived from
members of the genus Streptomyces, however, other so-called
“rare” actinomycetes are increasingly playing a more important
role in the production of biocompounds (Berdy, 2005; Kurtboke,
2010).
To fully understand the taxonomic distribution of the acti-
nobacterial strains identified to produce biosurfactants and
bioemulsifying compounds, taxonomic data of the class Acti-
nobacteria was evaluated. Information were retrieved from the
taxonomy browser of the National Center for Biotechnology
Information1 considering 16S rRNA gene sequence based reclas-
sifications according to Zhi et al. (2009) and Goodfellow and
Fiedler (2010). The order Thermoleophilales that has been reclas-
sified into a new class (Euzéby, 2013) has been excluded and the
1National Center for Biotechnology Information (NCBI) Taxonomy
Browser. Available online at: http://www.ncbi.nlm.nih.gov/Taxonomy/
Browser/wwwtax.cgi?mode=Undef&id=201174&lvl=5&lin (accessed 01.07.2014 -
07.01.2015).
recently identified order Gaiellales has been included (Euzéby,
2012). Overall, the class Actinobacteria contains five subclasses
and nine orders with a total of 54 families (Figure 1). The largest
order, Actinomycetales, is divided into 14 suborders and con-
tains by far the highest diversity within the class Actinobacteria.
It is therefore not surprising that biosurfactants reported in lit-
erature focuses on members of this order. The next few para-
graphs will go into more detail around the different types of
biosurfactants that have been identified to be produced by acti-
nobacterial strains, their production, purification and structural
elucidation, as well as the clear influence of the environment
the producer organism is found in and their ability to produce
biosurfactants.
Trehalose-Comprising Glycolipids
The best described biosurfactants amongst the actinobacteria
are glucose-based glycolipids, most of which have a hydrophilic
backbone consisting of two α,α-1,1 glycosidic linked glucose
units forming a trehalose moiety. Different types of trehalose-
containing glycolipids and their producers have been exten-
sively reviewed (Asselineau and Asselineau, 1978; Asselineau and
Lanéelle, 1998; Franzetti et al., 2010; Kuyukina and Ivshina, 2010;
Shao, 2011; Khan et al., 2012). Those of the class Actinobacteria
aremainly foundwithin the generaRhodococcus,Mycobacterium,
Nocardia, Arthrobacter and Corynebacterium, and less frequently
within the genera Tsukamurella, Brevibacterium, and Micrococ-
cus (Tables 1, 2). Different structures of trehalose lipid com-
prising amphiphilic molecules have been reported: Acyl chains
with glycosidic linkages to glucose or trehalose units have been
reported to vary in number of occurrence, length and type, as
well as the position (and number) of their linkage to the sugar
rings and exhibit different cellular functions.
For the hydrophobic moiety of trehalose-comprising glycol-
ipids, the structures of two main types of trehalose lipids have
been elucidated: those carrying a mycolic fatty acid ester and
those carrying a fatty acid ester.
The smallest hydrophilic backbone in glycolipids constitutes
glucose, the building block of the sugar dimer trehalose. Com-
plete structures of acylglucoses carrying mycolic acid esters have
been elucidated and reported to be produced by isolates belong-
ing to the genera Corynebacterium andMycobacterium (Brennan
et al., 1970) (Table 1), whereas acylglucoses carrying fatty acid
esters have been described for Brevibacterium spp. (Okazaki et al.,
1969) (Table 2).
Trehalose Lipid Mycolic Acid Esters
Mycolic acids are long-chain fatty acids and a major compo-
nent of the cell wall in various actinobacteria. Species-dependent,
its lengths varies from 22 to 92 carbon atoms; they possess
long β-hydroxy-α-branched acyl chains, including cyclopropane
patterns and oxygenic groups. The synthesis of mycolic acids
includes condensation reactions, and they are also referred to as
eumycolic acid, corynemycolic acid and nocardio-mycolic acid,
depending on their presence inMycobacterium spp., Corynebac-
terium spp., and Nocardia spp., respectively (Asselineau and
Lanéelle, 1998).
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TABLE 1 | Mycolic and corynemycolic containing trehalose lipids that are of actinobacterial origin.
Species Strain TL mycolic acid ester References
Arthrobacter paraffineus KY 4303 TL mycolic (C32–C36) Suzuki et al., 1969
Brevibacterium sp. KY 4304/4305 TL mycolic (C32–36) Suzuki et al., 1969
Brevibacterium vitarumen 12143 TL dimycolic (C28–C38) Lanéelle and Asselineau, 1977
Corynebacterium diphtheriae n.a. Glucose mycolic (C32) Brennan et al., 1970
Corynebacterium spp.
(fasciens, pseudodiphtheriae)
KY 3543
KY 3541
TL mycolic (C32–36) Suzuki et al., 1969
Corynebacterium matruchotii ATCC 14266 TL dimycolic (C28–C38) Datta and Takayama, 1993
Mycobacterium spp.
(smegmatis, tuberculosis)
BCG, n.a. Glucose mycolic (C32) Brennan et al., 1970
Mycobacterium spp.*
(bovis, fortuitum, kansaii, malmoense, phlei,
tuberculosis, smegmatis, szulgai, etc.)
Various TL mycolic, dimycolic, Reviewed in: Asselineau and Asselineau, 1978; Gautier
et al., 1992; Asselineau and Lanéelle, 1998; Vergne and
Daffé, 1998; Dembitsky, 2004; Ishikawa et al., 2009;
Shao, 2011
Nocardia spp. n.a. TL mycolic (C32–36) Suzuki et al., 1969
Rhodococcus spp.*
(erythropolis, opacus, ruber, etc.)
Various TL mycolic,dimycolic, Reviewed in: Asselineau and Asselineau, 1978; Lang
and Philp, 1998; Kuyukina and Ivshina, 2010; Shao,
2011; Khan et al., 2012
EXAMPLES OF MYCOLIC ACID CONTAINING TREHALOSE LIPIDS
1
Trehalose dimycolate produced by Mycobacterium tuberculosis
2
Trehalose dicorynemycolate produced by Rhodococcus erythropolis
*Several producing species are reported; TL, trehalose lipid; n.a., information not available.
Mycolic acid comprising trehalose lipids (Table 1) can be dis-
tinguished into two different types, the trehalose mycolic lipids
and the trehalose corynemycolic lipids. These mycobacterial tre-
halose mycolates or dimycolates are by far the most hydrophobic
glycolipids. Linked to C6 (and C6′) of the sugar rings, they vary
among species in length and branching. They are shaped to form
bilayers, implemented in the outer cell wall and usually not found
on the bacterial cell surface (Vergne and Daffé, 1998). Trehalose
dimycolates (1, Table 1), also referred to as “cord factor,” serve
a particular function for the cell. They act as virulence factors
and have immuno-modulating activity (Shao, 2011). They may
further be important to maintain a hydrophobic cell wall of the
organism hence facilitating the uptake of hydrophobic carbon
sources. The other type, trehalose lipids containing corynemy-
colic acid also carry β-hydroxy-α-branched fatty acid moieties
and have been described to occur within the genus Rhodococcus
(2, Table 1), carrying 30–56 carbon atoms and within the genus
Corynebacterium, carrying 22–36 carbon atoms. They are also
described to occur in mycobacteria (Brennan et al., 1970) and
found in trehalose lipids of Brevibacterium vitarumen (Lanéelle
and Asselineau, 1977), Arthrobacter paraffineus and a Nocar-
dia sp. (Suzuki et al., 1969). Corynemycolic acids are much
shorter than their mycobacterial counterparts: they lack func-
tional groups and are often unsaturated. Within virulent strains
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TABLE 2 | Trehalose lipid ester of actinobacterial origin.
Species Strain TL ester References
Arthrobacter sp. EK 1 TL tetraester (C12–C18) Passeri et al., 1990
Brevibacterium thiogenitalis No. 653 Glucose diester (C18) Okazaki et al., 1969
Micrococcus luteus BN56 TL tetraester (C9–C14) Tuleva et al., 2009
Mycobacterium spp.*
(africanum, bovis, fortuitum, tuberculosis, etc.)
Various TL ester Reviewed in: Vergne and Daffé, 1998;
Dembitsky, 2004; Shao, 2011
Mycobacterium tuberculosis H37Rv TL sulfolipid Goren, 1970; Gilleron et al., 2004
Nocardia farcinica BN26 TL succinic tetraester (C7-12) Christova et al., 2014
Rhodococcus spp.* (erythropolis, longus,
wratislavensis, etc.)
Various TL ester, TL succinic ester Reviewed in: Asselineau and Asselineau, 1978;
Lang and Philp, 1998; Kuyukina and Ivshina,
2010; Shao, 2011; Khan et al., 2012
Tsukamurella pulmonis PCM 2578T TL diester (C18–20/C4–5) Pasciak et al., 2010a
Tsukamurella spumae
Tsukamurella pseudospumae
DSM 44113,
DSM 44114
DSM 44117
TL diester (C16–18/C4–6) Kügler et al., 2014
Tsukamurella tyrosinosolvens DSM 44370 TL diester (C16–18/C2–6) Vollbrecht et al., 1998
EXAMPLES OF TREHALOSE LIPID ESTERS
3 4
Trehalose diester produced by Tsukamurella spumae Succinic trehalose tetraester produced by Nocardia farcinia
5
Diacetylated trehalose sulfolipid produced by Mycobacterium tuberculosis
*Several producing species are reported; TL, trehalose lipid.
ofmycobacteria, five different sulfonated forms of trehalose esters
have been found, varying in their acylation pattern (Khan et al.,
2012).
Trehalose Lipid Esters
Actinobacterial trehalose lipid esters are mainly acylated at
C6/C6′ or at C2/C3 and are summarized in Table 2. The amount
of hydrophobic chains linked to the trehalose unit varies from
one to four, forming trehalose mono-, di-, tri- and tetraesters,
but also octaesters (Singer et al., 1990) (3, Table 2). The acyl
chains varies in lengths from C8 to C20, show an unsaturated
pattern or form short succinoyl acids, giving the trehalose
lipid an anionic character (Lang and Philp, 1998; Tokumoto
et al., 2009) (4, Table 2). They are reported to be linked to
the chain length present in hydrophobic carbon source fed to
the producing strain. These glycolipid-linked medium chain
length fatty acids are found within the following actinobacterial
genera: Arthrobacter, Brevibacterium, Caseobacter, Micrococcus,
Mycobacterium, Nocardia, Rhodococcus, and Tsukamurella
(Table 2).
An exception among the trehalose lipid esters described, is sul-
folipid 1 (Goren, 1970) (5, Table 2), a sulfonated and acylated
trehalose lipid carrying phtio- and hydroxyphtioceranic com-
partments. They are known to contribute to the pathogenesis and
virulence of Mycobacterium tuberculosis, the causative agent of
tuberculosis. Diacyltrehalose sulfate, the biosynthetic precursor
for sulfolipid 1, has recently been isolated from M. tuberculo-
sis (Domenech et al., 2004) and has been used as a target for
T-cell mediated recognization and elimination ofM. tuberculosis
infected cells (Gilleron et al., 2004).
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Oligosaccharide Lipids
A glycosylated backbone of trehalose is found in oligosaccharide
lipids (Table 3) carrying two to five sugar units. Trisaccharide
lipids that have been reported for the class Actinobacteria all dif-
fer with respect to the acylation pattern of the third glucose unit.
One sugar of the 1-1′ linked di-glucose backbone is further linked
to a third sugar unit at C2 in the hydrophilic moeity of oligosac-
charides produced byMycobacterium leprae (Brennan, 1989) and
Tsukamurella tyrosinosolvens (Vollbrecht et al., 1998). The third
sugar unit is linked at C3 in a terrestrial actinomycete reported
by Esch et al. (1999) and at C4 in a Rhodococcus sp. (Konishi
et al., 2014) (6, Table 3). They also differ with respect to their
hydrophobic nature. The latter two are acylated at all three sugar
units, both carrying a C6 fatty acid moiety at the third sugar unit
and succinic acid at the first sugar unit. Something that is rather
exceptional is the acylation pattern at the trehalose backbone that,
in its hydrophobic moieties, carries at each unit an acyloxyacyl
structure in the O-ester linkage to the carbohydrate where the 3-
hydroxy C8 or C10 fatty acid moiety is further acylated with a C6
fatty acid (6, Table 3). The Tsukamurella sp. trisaccharide lipids
are acylated at two sugar units, each carrying two ordinary C8–
C10 fatty acid units. Furthermore, a tetrasaccharide lipid form
of this glycolipid has also been found to occur (Vollbrecht et al.,
1998) (7, Table 3).
Non-trehalose based oligosaccharide lipids are found within
phenol-phtiocerol glycosides in various mycobacteria. These
TABLE 3 | Actinobacterial oligosaccharide lipids.
Species Strain Oligosaccharid lipids References
Mycobacterium spp.*
(avium, kansaii, leprae, linda, malmoense, smegmatis, szulgai,
tuberculosis)
Various oligosaccharide ester, phenolic
glycolipids
Reviewed in: Saadat and Ballou,
1983; Brennan, 1989;
Dembitsky, 2005b
Nocardia corynebacteroides SM1 Pentasaccharide succinic octaester
(C2–C8)
Powalla et al., 1989
Rhodococcus sp.
Rhodococcus fascians
NBRC 1097287
NBRC 12155
Trisaccharid succinic tetraester
(C8-O-C6/C6)
Konishi et al., 2014
Tsukamurella tyrosinosolvens DSM 44370 Tri/tetrasaccharide ester (C8-10) Vollbrecht et al., 1998
EXAMPLES OF OLIGOSACCHARIDE LIPIDS
6 7
Succinic trisaccharide lipid produced by Rhodococcus fascians Tetrasaccharide lipid produced by Tsukamurella tyrosinosolvens
8
Methylated dirhamnose/glucose phenol phtiocerol named phenolic glycolipid I of Mycobacterium leprae Brennan, 1989
*Several producing strains are reported.
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oligosaccharide lipids, also termed phenolic glycolipids, contain
tri- and tetraglycosyl units composed of various methylated sug-
ars that are mainly based on rhamnose and partly on fucose,
glucose and arabinose (Brennan, 1989). The rarely described phe-
nolic acylation pattern is bound to dimycocerosyl phtiocerol acyl
groups. The phenolic glycolipid I ofM. leprae carries three myco-
cerosyl acyl groups each in length of C30–C34 (Brennan, 1989)
(8, Table 3).
In industrial and environmental processes the potential of tre-
halose lipids could become valuable as they have shown interest-
ing properties in several studies that focus on the remediation
of hydrocarbon contaminated soils, the removal of suspended
solids fromwastewater (Franzetti et al., 2010) and in enhanced oil
recovery (Christofi and Ivshina, 2002). However, most research
are centered around the bio-activity of trehalose lipid molecules
that exhibit biomedical properties such as antimicrobial, antiviral
(Azuma et al., 1987; Watanabe et al., 1999; Shao, 2011) and anti-
tumor activities (Sudo et al., 2000; Franzetti et al., 2010; Gudiña
et al., 2013). Due to their functions in cell membrane interactions
they can act as therapeutic agents (Zaragoza et al., 2009; Shao,
2011) or have an impact on the pathogenesis of causative agents
of infections, such as those caused by pathogenic M. tuberculo-
sis, Corynebacterium diphteriae, and the opportunistic pathogens,
Mycobacterium avium, Mycobacterium intracellulare, Nocardia
asteroides, Corynebacterium matruchotii, and Corynebacterium
xerosis (Kuyukina and Ivshina, 2010). Trehalose lipids can be
excreted into the cultivation supernatant or can be produced as
non-covalently linked lipids bound to the cell wall or they can
be cell wall integrated thus posing limits to quantities produced
by the organisms, a disadvantage for its potential exploitation in
large scale production processes.
Non-Trehalose Glyolipids
Hexose-Comprising Glycolipids
Besides the trehalose-containing biosurfactants and its con-
geners, several glycolipids have been elucidated that are produced
by actinobacteria and share other hydrophilic moieties. By simply
varying the carbon source in the growth media from n-alkanes to
either sucrose or fructose, the hydrophilic part of the surfactant
produced was reported to be switched from trehalose to fructose
by members of the genus Arthrobacter, Corynebacterium, Nocar-
dia, Brevibacterium, andMycobacterium (Itoh and Suzuki, 1974)
and sucrose in the case of the same genera exceptMycobacterium
(Suzuki et al., 1974). Compounds for which structures have been
elucidated are listed in Table 4.
Besides the rhamnose-containing phenolic glycolipids men-
tioned in the oligosaccharide lipid section, the occurrence of
other rhamnose-based lipids have recently been detected in a
deep sea isolate identified as Dietzia maris (Wang et al., 2014)
and has been identified as a C10:C10 di-rhamnolipid. This repre-
sents a unique occurrence within the class Actinobacteria. Other
rhamnolipid producing actinobacteria are admittedly declared
as producing strains in literature, however the surface active
compounds produced have either not been elucidated or iden-
tified as rhamnolipids with debatable structural characteriza-
tions (Rhodoccocus fascians Gesheva et al., 2010, Renibacterium
salonariumChristova et al., 2004, and aNocardioides sp. Vasileva-
Tonkova and Gesheva, 2005) (Table 11).
A different group of glycolipids are lipidic structures based
on dimannose. Typically they are linked via a glycerol unit
to different numbers of fatty acid chains. They have been
reviewed in Shaw (1970) and structures have been identified
for compounds produced by species belonging to the actinobac-
terial genera Micrococcus (Lennarz and Talamo, 1966), Curto-
bacterium (Mordarska et al., 1992), Saccharopolyspora (Gamian
et al., 1996), Rothia (Pasciak et al., 2002, 2004), Nocardiop-
sis (Pasciak et al., 2004), Arthrobacter (Pasciak et al., 2010b)
as well as the strain Sinomonas atrocyaneus (Niepel et al.,
1997), formerly classified as Arthrobacter atrocyaneus. These di-
mannose based glycolipids are composed of hydrophilic α-D-
mannopyranose dimers linked with two C14–C16 iso or anteiso
fatty acid chains. One chain is directly esterified to the C6
hydroxyl group of one sugar unit, while the second fatty acid
chain is linked via a glycerol moiety to the C3 of the same
sugar unit. The glycerol moiety is monoacylated at either the
primary or secondary methylene position (9, Table 4) and its
acylation site can be used to distinguish taxonomic proper-
ties of the different producer strains. These compounds have
been isolated intracellularly and they act as precursors and cell
membrane anchors for the synthesis of lipoarabinomannan, a
polymeric surfactant and actinobacterial cell wall component
(Pakkiri and Waechter, 2005) (see section on polymeric biosur-
factants).
The coexistence of galactosyl diglycerides (10, Table 4) in
Arthrobacter scleromae and Arthrobacter globiformis (Pasciak
et al., 2010b) have been described and can be used as a gly-
comarker to distinguish these strains from the opportunistic
pathogens, Rothia mucilaginosa and Rothia dentocariosa (Pasciak
et al., 2002, 2004).
Macrocyclic Glycosides
Among the biosurfactants produced by actinobacteria, macro-
cyclic glycosides (Table 5) and macrocylcic dilactones (Table 6)
can be distinguished and are often known to exhibit bio-activity
against a range of organisms. The aliphatic macrolide antibiotic,
brasilinolide, is produced by Nocardia brasiliensis and exhibits
both antifungal and antibacterial activity. Three different vari-
ants have been described by Tanaka et al. (1997), Mikami et al.
(2000) and Komatsu et al. (2004). All consist of a C32-membered
macrolide with a sugar moiety but differ with regards to the acy-
lation site of a malonic acid ester side chain (11, Table 5). The
C16-membered dimeric macrolide elaiophylin and its variants
have been isolated from various Streptomyces spp. including high
producer strains. It exhibits bio-active properties against intesti-
nal worms as well as antimicrobial, antitumor and immunosup-
pressant activities. A putative 95 kbp biosynthetic gene cluster of
elaiophylin has been proposed (Haydock et al., 2004). Dembitsky
(2005a,c) reviewed the different types of C14-membered lactam
rings that are attached to an aminosugar (12, Table 5). Fluvirucin
has been isolated from various Actinomadura spp., Streptomyces
spp., Microtetraspora spp., and Saccharotrix mutabilis. The dif-
ferent fluvirucins share a common lactam ring unit but differ
in terms of glycosylation. All of them act as potent antifungal
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TABLE 4 | Non-trehalose comprising glycolipids produced by actinobacteria.
Species Strain Hexose lipids References
Arthrobacter paraffineus KY 4303 Sucrose mycolic (C32–C36)* Suzuki et al., 1974
Arthrobacter paraffineus KY 4303 Fructose coryne- and dicorynemycolic* Itoh and Suzuki, 1974
Arthrobacter spp.
(globiformis, scleromae)
ATCC 8010T
YH 2001T
Dimannosylacyl (C15–C17) monoglyceride (C15–C17)
Galactosyl diglyceride(C15–C17)
Pasciak et al., 2010b
Brevibacterium butanicum KY 4332 Fructose coryne- and dicorynemycolic* Itoh and Suzuki, 1974
Brevibacterium spp. n.a. Sucrose mycolic (C32–C36)* Suzuki et al., 1974
Corynebacterium spp. n.a. Sucrose mycolic (C32–C36)* Suzuki et al., 1974
Corynebacterium spp. n.a. Fructose coryne- and dicorynemycolic* Itoh and Suzuki, 1974
Curtobacterium flaccumfaciens ATCC 13437 Di- and trimannosylglyceride (C18–C19 cyclopropane) Mordarska et al., 1992
Dietzia maris MCCC 1A00160 Rhamnolipid (C10/C10) Wang et al., 2014
Micrococcus lysodeikticus ATCC 4698 Dimannosylglyceride (C14) Lennarz and Talamo, 1966
Mycobacterium avium
Mycobacterium koda
KY 3844
KY 3852
Fructose coryne- and dicorynemycolic* Itoh and Suzuki, 1974
Nocardia butanica
Nocardia convulutus
KY 4333
KY 3907
Sucrose mycolic (C32–C36)* Suzuki et al., 1974
Nocardia rubra
Nocardia butanica
Nocardia convulutus
KY 3844
KY 4333
KY 3907
Fructose coryne- and dicorynemycolic* Itoh and Suzuki, 1974
Nocardiopsis dassonvillei PCM 2492T (ATCC 23218) Dimannosylacyl (C15) monoglyceride (C16) Pasciak et al., 2004
Rothia dentocariosa PCM 2249T (ATCC 17931) Dimannosylacyl monoglyceride (C16–C19) Mordarska et al., 1992;
Pasciak et al., 2002
Rothia mucilaginosa PCM 2415T (ATCC 25296T ) Dimannosylacyl (C15) monoglyceride (C16) Pasciak et al., 2004
Saccharopolyspora spp.
(erythraea, hirsuta, rectivirgula, sp.)
ATCC 27875T
ATCC 11635T
IMRU1258
LL-100-46)
Dimannosylacyl (C15–C16) monoglyceride (C16) Gamian et al., 1996;
Pasciak et al., 2002, 2004
Sinomonas artrocyaneus LMG 3814T Dimannoseylacyl (C14) monoglyceride (C16) Niepel et al., 1997
EXAMPLES OF NON-TREHALOSE COMPRISING HEXOSELIPIDS
9 10
Dimannosylacyl monoglyceride produced by Rothia mucilaginosa Galactosyl diglyceride produced by Arthorbacter globiformis and Arthrobacter scleromae
n.a., no information available; *Sucrose and fructose based surfactants are variants of trehalose lipids.
agents against Candida spp. and show antiviral properties against
influenza A virus (Dembitsky, 2005c).
Among the macrocyclic dilactones, glucolypsin, an acylglu-
cose dimer has been isolated from Streptomyces purpurogeniscle-
roticus and Nocardia vaccinii by Qian-Cutrone et al. (1999). This
extraordinary glycolipid is formed out of two glucose units linked
to identical iso-branched C18 acyl chains that each carry a methyl
group at C2 and a hydroxyl group at C3 of the acyl chain. By con-
necting the C6′ of the glucose molecule to the carboxy-C1 of the
fatty acid chain, a rotationally symmetric dimer is formed (13,
Table 6). Glucolypsin variants with C18 and C17 fatty acid chains
of the same type also occur. Glycolypsin is reported to increase
the activity of glucokinases by relieving its inhibition via long
chain fatty acyl CoA esters (Qian-Cutrone et al., 1999). Derivates
of glucolypsin that share a common backbone, have been shown
to exhibit antiviral and antibiotic properties. In contrast to glu-
colypsin, the acylglucose dimer of fattiviracins (C24/C26) and
cycloviracins (C24/C33) are built up out of trihydroxy fatty
acids, each of them glycosidic linked to a further glucose unit
at the third hydroxyl group. Cycloviracins are characterized by
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TABLE 5 | Macrocyclic glycosides produced by actinobacteria.
Species Strain Macrocyclic glycoside References
Actinomadura spp.*
(roseorufa roseorura, vulgaris, yumaensis)
Various Fluvirucin (14C macrolide) Reviewed in: Dembitsky,
2005a,c
Microtetraspora pusilla R359-5 Fluvirucin B1 (14C macrolide) Dembitsky, 2005a
Microtetraspora tyrrheni Q464-31 Fluvirucins (14C macrolide) Dembitsky, 2005a,c
Nocardia brasiliensis IFM 0406 Brasilinolide A, B, C
(32C macrolide)
Tanaka et al., 1997; Mikami et al.,
2000; Komatsu et al., 2004
Saccharothrix mutabilis R869-9 Fluvirucin A2 (14C macrolide) Dembitsky, 2005a
Streptomyces spp.*
(antibioticus, erythreus, felleus, hygroscopicus, melanosporus,
narbonensis, spinichromogenes, violaceoniger)
various Elaiophylin and derivates
(16C macrolide)
Fluvirucin (14C macrolide)
Reviewed in: Dembitsky, 2005a
EXAMPLES OF MACROCYCLIC GLYCOSIDES
11 12
Brasilinoide A produced by Nocardia brasiliensis Fluvirucin B1 produced by Actinomadura vulgaris subsp. lanata
*Several producing strains are reported.
a fifth glucose unit bound to the C26 fatty acid chain, the three
non-cyclic sugar units are methoxylated at C2, and the methyl
branches at C2 of the fatty acid moieties are missing. Congeners
of fattiviracin are divided into five families according to the
length of their fatty acid moiety with each family showing similar
antiviral activity against herpes, influenza and human immunod-
eficiency viruses (Uyeda, 2003). No alterations in the fatty acid
chain length of cycloviracins have been reported. Fattiviracins
(14, Table 6) have been shown to be produced by Streptomyces
microflavus (Uyeda et al., 1998) and cycloviracins (15, Table 6)
by Kibdelosporangium albatum (Tsunakawa et al., 1992b).
Terpenoids and Terpene Glycosides
Actinobacterial terpenoid and terpene glycosides are summarized
in Table 7. Vancoresmycin is a C65 highly oxygenated terpenoid
glycoside produced by an Amycolatopsis sp. It contains a tetramic
acid unit and is glycosidic linked to a methylated carbohydrate
moiety containing one amino group (16, Table 7). Antimicrobial
effect against various bacteria was reported by Hopmann et al.
(2002), most notably against species resistant to the antibiotic
vancomycin (often considered to be the antibiotic of last resort
for the treatment of resistant bacteria). Besides the terpenoid gly-
coside, several different types of terpene glycosides are produced
by actinobacterial strains. They are surfactants that mostly carry
terminal hydrophilic groups linked by a hydrophobic carotenoid
moiety.
Terpene glycosides have been elucidated as products obtained
from members of the following genera: Corynebacterium
(Weeks and Andrewes, 1970), Arthrobacter (Arpin et al., 1972),
Rhodococcus (Takaichi et al., 1997), and Micrococcus (Osawa
et al., 2010) (Table 7). Most of them share a backbone of a
C50 atom carotenoid. They can either be linked to one or
two hydroxyl groups at the terminal ends (decaprenoxanthin
and sarcinaxanthin) or one hydroxyl group and one glycosidic
moiety (corynexanthin, decaprenoxanthin monoglycoside and
sarcinaxanthin monoglycoside). Di-glycosylated forms are found
within Arthrobacter and Micrococcus (decaprenoxanthin diglu-
coside and sarcinaxanthin diglucoside) (17, Table 7) and further
exist as an acetylated form at all hydroxyl groups. The terpene
glycosides produced by Rhodococcus rhodochrous, differ from the
one mentioned above, as they contain a monocyclic carotenoid
backbone linked to a glucopyranosyl residue at the non-cyclic
end (18, Table 7). The glucose unit is further acylated at C6 to
a C36–C50 mycolic acid moiety leading to carotenoid glucoside
mycolic acid esters. These terpene glycosides are mainly found in
pigmented bacteria and it is hypothesized that they act as antiox-
idants to protect organisms from injuries caused by free radicals
(Osawa et al., 2010).
Polymeric Biosurfactants
The most common polymeric surfactants produced by
actinobacteria are macro-amphiphilic lipoglycans such as
lipoarabinomannan and its precursors, lipomannan and phos-
phatidylinositol mannosides. In contrast to the core of the
actinobacterial cell wall, arabinogalactan and peptidoglycan,
these polymeric lipoglycans are non-covalently attached to the
cell membrane although phosphatidylinositol mannides are
structurally related to lipomannan and lipoarabinomannan
anchor units. These polymeric glycolipids have been isolated
from Mycobacterium spp., Gordonia spp., Rhodococcus spp.,
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TABLE 6 | Macrocyclic dilactones produced by actinobacteria.
Species Strain Macrocyclic dilactones References
Kibdelosporangium albatum ATCC 55061 Cycloviracin B1 and B2 (C23/C26) Tsunakawa et al., 1992a,b
Nocardia vaccinii WC65712 Glucolypsin A and B (C19/C19) Qian-Cutrone et al., 1999
Streptomyces microflavus No.2445 Fattiviracin a1 (C22–28/C22–24) Uyeda et al., 1998; Yokomizo et al., 1998
Streptomyces purpurogeniscleroticus WC71634 Glucolypsin A and B (C19/C19) Qian-Cutrone et al., 1999
EXAMPLES OF MACROCYCLIC DILACTONES
13
Glucolypsin A produced by Nocardia vaccinii and Streptomyces purpurogeniscleroticus
14
Fattiviracin produced by Streptomyces microflavus
15
Cycloviracin B1 produced by Kibdelosporangium albatum
Dietzia maris, Tsukamurella paurometabolus, Turicella otitidis,
and Amycolatopsis sulphurea (Table 8). Except for A. sulphurea,
all of these strains belong to the suborder Corynebacteridae that
are known to contain mycolic acids in their cell wall. It comprises
the presence of mycolic acids and contain lipid rich cell envelope
structures (Sutcliffe, 1997) forming an extremely robust and
impermeable cell envelope (Berg et al., 2007). Lipoarabinoman-
nans are well known to cause immunorepressive functions in
diseases such as tuberculosis and leprosy that are caused by the
pathogenic mycobacterial strains M. tuberculosis and M. leprae.
However, non-pathogenic species have also been shown to pro-
duce lipoarabinomannans and are reported to have an opposite
effect thus stimulating pro-inflammatory responses (Briken et al.,
2004). The mannan core of lipoarabinomannan and the number
of branching units is species dependent. Further differences
in its structure is traced back to capping motifs present at the
non-reducing termini of the arabinosyl side chains. Mannan
caps are mainly present in pathogenic strains, whereas inositol
phosphate caps are present in non-pathogenic mycobacteria
(Briken et al., 2004). Lipoarabinomannans show structural
similarity to its precursors lipomannan and phosphatidylinositol
mannoside and consist of an α-1,6 linked mannan core with
frequent α-1,2 mannose branches leading to a mannan backbone
of approximately 20–25 mannose residues substituted with
arabinofuran residues that carry terminal extension motifs,
which vary among the producer species (Berg et al., 2007). The
lipophilic part consists mainly of C16 glycerides that are linked
to the mannan core by a phosphate group (19, Table 8).
Lipopeptides
Cyclic and linear lipopeptides are produced by various actinobac-
terial strains and are summarized in Table 9.
Cyclic Lipopeptides
Cyclic lipopeptides are the most common type of lipopeptides
and consist of a peptide chain of various types and numbers
of amino acids circularized and linked to mainly one fatty acid
Frontiers in Microbiology | www.frontiersin.org 10 March 2015 | Volume 6 | Article 212
Kügler et al. Surfactants tailored by the class Actinobacteria
TABLE 7 | Terpenoid and terpene-containing biosurfactants produced by actinobacteria.
Species Strain Terpenoids and terpenes References
Amycolatopsis sp. DSM 12216 Vancoresmycin (65C terpenoid) Hopmann et al., 2002
Arthrobacter sp. M3 Corynexanthin mono- and diglycosides (C50 terpene) Arpin et al., 1972; Dembitsky, 2005b
Corynebacterium sp. CMB 8 Corynexanthin (C50 terpene) Weeks and Andrewes, 1970
Micrococcus yunnanensis AOY-1 Sarcinaxanthin, sarcinaxanthin mono- and diglucosides (C50 terpene) Osawa et al., 2010
Rhodococcus rhodochrous RNMS1 Carotenoid (C40 terpene) glycoside (C36–C50 mycolic) Takaichi et al., 1997
EXAMPLES OF TERPENE AND TERPENOID GLYCOSIDES
16
The terpenoidic glycoside vancoresmycin produced by Amycolatopsis sp.
17
Sarcinaxanthin diglycoside produced by Micrococcus yunnanensis
18
Carotenoid glycoside esterified with a rhodococcus type mycolic acid produced by Rhodococcus rhodochrous
chain. A surfactant often falsely cited to be produced by an
actinobacterium but not of actinobacterial nature, is the eleven
amino acid cyclic lipopeptide arthrofactin. It was initially pos-
tulated to be produced by an Arthrobacter sp. (Morikawa et al.,
1993) but later corrected to originate from a Pseudomonas strain
(Roongsawang et al., 2003).
Cyclic lipopeptides that have been reported within the class
Actinobacteria are the six amino acid containing cystargamide
produced by Kitasatospora cystarginea (Gill et al., 2014) (20,
Table 9), the thirteen amino acid containing daptomycin pro-
duced by Streptomyces roseosporus (Debono et al., 1987) (21,
Table 9) and the depsipeptide ramoplanin, containing 16 amino
acids, and which is produced by an Actinoplanes sp. (Ciabatti
et al., 1989) (22, Table 9). All of them are cyclic due to an ester
linkage between the carboxyl terminus and a hydroxyl group of
either a threonine or hydroxyl-asparagine.
In cystargamide, the smallest cyclic lipopeptide, an
uncommon 2,3 epoxy fatty acid chain (C10) is linked to
the threonine amine. Besides proteinogenic amino acids,
cystargamide further contains rare 5′-hydroxy-trypthophan and
4′-hydroxyphenylglycine (20, Table 9). No antimicrobial activity
of cystargamide could be demonstrated (Gill et al., 2014).
An outstanding example of successful screening for a surfac-
tant with bioactive properties are A21978C complexes, known as
precursors of daptomycin. They were structurally elucidated in
1987 (Debono et al., 1987) and A21978C comprises thirteen dif-
ferent amino acids, 10 of them in the cyclic part of the structure
and three in the extension of the hydrophobic tail (21, Table 9).
Three different lipophilic tails are known, C10 anteiso, C11 iso
branched and C12 anteiso. The most bioactive form of A21978C
is daptomycin and has been generated by enzymatic deacyla-
tion of the mixture of lipophilic tails and chemical reacylation
with a decanoyl fatty acid moiety. It was approved by the U.S.
Food and Drug Association (FDA) in 2003 as the first antibiotic
of its kind, and commercialized as cubicin R©. It is active against
various gram positive bacteria including the methicilin-resistant
pathogen Staphylococcus aureus, penicillin-resistant Streptococ-
cus pneumoniae and vancomycin resistant enterococci (Miao
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TABLE 8 | Polymeric glycolipids of actinobacterial origin.
Species Strain Polymeric glycolipid References
Corynebacterium matruchotii NCTC 10207 Lipoarabinomannan Sutcliffe, 1995
Turicella otitidis DSM 8821 Lipoarabinomannan Gilleron et al., 2005
Dietzia maris N1015 Lipoarabinomannan Sutcliffe, 2000
Mycobacterium spp.*
(avium, bovis, chelonae, fortuitum, kansaii,
leprae, smegmatis, tuberculosis, etc.)
Various Lipoarabinomannan and lipomannan Reviewed in: Chatterjee and Khoo,
1998; Brennan, 2003; Nigou et al.,
2003; Briken et al., 2004
Gordonia bronchialis N654T Lipoarabinomannan, phosphatidylinositol mannoside Garton and Sutcliffe, 2006
Gordonia rubripertincta ATCC 25689 Lipoarabinomannan, phosphatidylinositol mannoside Flaherty and Sutcliffe, 1999
Rhodococcus spp.*
(equi, rhodnii, ruber, etc)
Various Lipoarabinomannan Reviewed in: Sutcliffe, 1997
Tsukamurella paurometabola DSM 20162 Lipoarabinomannan Gibson et al., 2004
Amycolatopsis sulphurea DSM 46092 Lipoarabinomannan Gibson et al., 2003
EXAMPLE OF LIPOARABINOMANNAN
19
Simplified structure of lipoarabinomannan produced by Mycobacterium tuberculosis with only one arabinofuran branch shown. Modified from Berg et al. (2007)
*Several producing strains are reported.
et al., 2005). Its ability to act as an antimicrobial requires the
presence of calcium. The cyclic lipopeptide oligomerizes and uses
its C10 hydrophobic tail to interact with the bacterial membrane
creating a membrane perforation and cell death. This displays a
novel mode of action among antimicrobial agents. Daptomycin
shows high activity and a resistance to its mechanism is more
difficult to generate compared to conventional antibiotics (Vil-
hena and Bettencourt, 2012). It is produced by a non-ribosomal
peptide synthetase (NRPS) in S. roseosporus. The NRPS contains
three subunits whose main genes have recently been identified in
a 128 kb cluster as dptA, dptBC, and dptD (Miao et al., 2005) with
several other genes necessary to synthesize an active form of dap-
tomycin. Its production yield of approximately 0.5 g l−1, is rela-
tively low compared to industrial production of other microbial
products. Current attempts for a heterologous production not
only target novel congeners of daptomycin but also the search
for high producing strains. Similar production yields compared
to the wild type strain have been reported for heterologous pro-
duction which was developed using a combination of metabolic
flux analysis and genetic modifications (Huang et al., 2012).
Antimicrobial activity against gram positive bacteria has also
been detected for ramoplanin produced by an Actinoplanes
sp. It contains 17 amino acids, 16 of which are part of the
cyclic section of the compound. It is further glycosylated at a
hydroxyphenylglycine with either di-mannose (Ciabatti et al.,
1989) or mannose (Gastaldo et al., 1992), thus its classification
as a glycolipopeptide. Besides its glycosylation pattern, mem-
bers of ramoplanin can be differentiated by their acyl amides
that consist of different di-unsaturated fatty acids linked to
the distal hydroxyl-asparagine. The fatty acid chain varies in
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TABLE 9 | Lipopeptides produced by actinobacterial strains.
Species Strain Lipopeptide References
Actinoplanes sp. ATCC 33076 Ramoplanin (glycosylated 17aa, C8–C10) Ciabatti et al., 1989; Gastaldo et al.,
1992
Kitasatospora cystarginea NRRL-B16505 Cystargamide (6aa, 2′-3′epoxy-C10) Gill et al., 2014
Rhodococcus sp. MCCC 1A00197 rhodocfactin Peng et al., 2008
Streptomyces roseosporus NRRL 11379 A21978C (daptomycin) (13aa, C10–12) Debono et al., 1987
Streptomyces tendae Tü 901/8c Streptofactin Richter et al., 1998
Streptosporangium amethystogenes subsp. fukuiense AL-23456 TAN-1511 A, B, C Takizawa et al., 1995
EXAMPLES OF LIPOPEPTIDES
20 21
Cystargamide produced by Kitasatospora cystarginea Daptomycin reacylated with decanoic acid from the core complex A21978C, produced
by Streptomyces roseasporus
22
Dimannosylated ramoplanin produced by Actinoplanes sp.
23
Linear TAN-1511 A produced by Streptosporangium amethystogenes subsp. fukuiense
aa, amino acid.
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length between C8 and terminal branched C9 and C10 (22,
Table 9).
A peptide-based surfactant produced by Streptomyces tendae,
streptofactin, was found to contain hydrophobic amino acids, but
lacked fatty acid chains (Richter et al., 1998).
Linear Lipopeptides
Linear lipopeptides have been found in Streptosporangium
amethystogenes (Takizawa et al., 1995). They are reported to
protect against infections in patients with leucopenia caused by
cancer therapies by stimulating bone marrow cells. Different
structures of these compounds are described, all share a 4′-thio
C7 fatty acid chain with two ester linked C16–C19 fatty acid
chains and one amide linked C13–C15 fatty acid chain. Three
glycine amino acids are linked at the amide bond of the thio fatty
acid with three to four proceeding amino acids varying in type
(23, Table 9).
Other Actinobacterial Biosurfactants
Phenazine Ester
Phenazines are a rare class of alkaloid esters. A marine
Streptomyces sp. has been described to produce a phenazine
ester that contain the desoxy pyranose quinovose ester-
ified at either C3 or C4 to the carboxyl end of the
phenazine. This phenazine-quinovose ester has been
shown to exhibit antimicrobial activity. Several differ-
ent types of the compound have been characterized
also varying in hydroxylation and acetylation pattern
at the desoxyglucose unit (Pathirana et al., 1992) (24,
Table 10).
Amide Glycosides
Various surfactants with nucleoside fatty amide glycoside
structure are produced by actinobacteria. A group of amide glu-
cosides is based on the uracil and disaccharide-containing tuni-
camycin, a glycoprotein with antibacterial properties (Dembit-
sky, 2005c). In this glycoprotein, two saturated or unsaturated
partly branched fatty acid chains varying in length are linked via
an amide to the galactosamine/glucosamine disaccharide. Besides
tunicamycin, produced by Streptomyces spp., the tunicamycin-
based surfactants streptovirudin (containing dihydrouracil) and
corynetoxin (25, Table 10) have been reported. The latter is pro-
duced by Corynebacterium rathayi, a pathogen of rye grass. The
organism multiplies within the galls of sheep spreading the toxic
metabolite (Frahn et al., 1984). In addition, the inhibitors of
bacterial peptidoglycan synthesis, liposidomycin A, B, and C,
have been reported to be produced by Streptomyces griseosporus.
Liposidomycin A contains the so far uniquely described fatty acid
composition of 3′-hydroxy-7,10-hexadecanoic acid (Dembitsky,
2005c) (26, Table 10).
Not Yet Elucidated Surfactants and their
Producing Strains
Surface or emulsifying activity has been observed to occur
from secondary metabolites of other members of the class
Actinobacteria. Table 11 gives an overview of strains that are
described to produce surface active compounds. Only some of
the structures of these compounds have been partially eluci-
dated.
Partly characterized surface active flocculants consisting of
lipids, fatty acids and corynemycolic fatty acids of Corynebac-
terium lepus have been described by Cooper et al. (1979b). In
addition, eleven different glycolipids that consist of hexoses and
pentoses linked to diverse fatty acid moieties that vary in length
of C10–C18 have also been described.
Besides D. maris (see glycolipid section), three other puta-
tive rhamnolipid-producing actinobacteria have been described.
Vasileva-Tonkova and Gesheva (2005) and Gesheva et al. (2010)
detected thin layer retention values equal to L-rhamnose after
acid hydrolysis of a biosurfactant produced by a Nocardioides sp.
and Rhodococcus fascians. The putative rhamnolipid was not fur-
ther examined in terms of the hydrophilic moiety or fatty acid
compositions. Christova et al. (2004) reported the production
of rhamnolipid by Renibacterium solmonarium in comparison
to commercial rhamnolipids in thin layer chromatography and
infrared spectroscopy. The infrared spectra showed homologies
to ester and carboxylic groups; thin layer chromatographic data
were not shown in the study. In all cases the detection of rham-
nolipids were putative and further structural analyses remains
necessary for confirmation.
Other surface active compounds were only putatively classi-
fied based on the component analysis of the crude extract toward
lipid, peptide and carbohydrate compositions. Based on this lim-
ited information, it was concluded that the production of either
glycolipids or lipopeptides took place (Table 11).
Mass spectroscopic analysis greatly assisted to partly charac-
terize the putative wax esters produced by D. maris (Nakano
et al., 2011). In addition, Kiran et al. (2010a,b, 2014) described the
production of furan-containing glycolipids in Brachybacterium
spp., Brevibacterium spp., and Nocardiopsis spp. By analyzing
hydrophilic and hydrophobic moieties after acid hydrolization,
database comparison of gas chromatography-mass spectroscopic
plots were used. 1HNMR evaluation of compounds from the two
latter strains were described to approve the resulting structure,
however relative data were not shown.
Similar results have been observed for surface active extracts
with a majority of peptidic compounds in the hydrophilic
part in Brevibacterium aurum (Kiran et al., 2010c) where
fractions of the biosurfactant showed molecular weights of
C9–C29 methyl esters and a mass that putatively confers to
a proline-leucine-glycine-glycine amino acid chain. However,
mass spectroscopic database comparisons remains putative.
Leucobacter komagate is described to produce surfactin or a
surfactin-like lipopeptide. This was concluded from mass spec-
troscopy, 1H NMR and infrared spectral data by Saimmai et al.
(2012b), but the full elucidation of the structures could not be
achieved.
The long list of non-elucidated actinobacterial surface active
compounds underlines the extraordinary potential of finding
novel biosurfactants in actinobacteria and displays the great need
for structure elucidation to allow for a better understanding of
the novelty and biodiversity of the compounds produced.
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TABLE 10 | Other biosurfactants produced by actinobacteria.
Species Strain Compound References
Streptomyces sp. CNB-253 Phenazine-quinovose Pathirana et al., 1992
Streptomyces spp.*
(griseoflavus, griseosporus, halstedii,
lysosuperficus, nursei, vinausdrappus)
various Fatty acid amide glycoside
(Tunicamycin, Streptovirudin, Liposidomycins)
Reviewed in: Dembitsky, 2005c
Corynebacterium rathayi n.a. Corynetoxin Frahn et al., 1984
EXAMPLES
24 25
Phenanzine-quinovose ester produced by Streptomyces sp. Corynetoxin produced by Corynebacterium rathayi
26
Liposidomycin A produced by Streptomyces sp.
*Several producing strains are reported.
Structural Elucidations of Actinobacterial
Surfactants
Various factors have been shown to influence the production,
extraction, purification and structure elucidation of novel
biosurfactants produced by actinobacterial strains. Due to their
phenotypic growth characteristics, distinct membrane compo-
sitions and their function within the utilization of hydrocar-
bons, the surfactants produced are often membrane integrated,
membrane associated, extracellular or a mixture of the above,
and is always dependent on their particular function within the
producing strains. Commonly the compounds produced exhibit
antimicrobial properties, on the one hand proposing wide rang-
ing applications, on the other resulting in opposing challenges
during the production process. Special considerations are nec-
essary when aiming for the extraction of the compound in an
adequate amount and purity for structural elucidation as well as
surfactant characterization. This section gives an overview of the
most common techniques used to achieve successful structural
elucidations.
Detection
Novel surfactant producing strains can be detected through the
use of screening assays that determine a surfactant’s activity either
from liquid culture (cell-free supernatant or culture broth) or
from solid agar plates. Various detection methods have been
described, but they mostly focus on changes observed in surface
tension or the solubilization and emulsification of hydrocarbons.
High throughput compatible assays can be distinct from more
precise assays that need several milliliters of the compound to be
tested. The latter often are also applied to characterize the activity
of a purified biosurfactant. Good reviews on screening techniques
have been summarized by Walter et al. (2010) and Satpute et al.
(2010).
Production
The manufacturing capacity of biosurfactants by a bacterial cul-
ture is limited. Wild type producing strains of the best described
microbial surfactants, cultured with optimized process methods
in suitable media and culture vessels reach production quanti-
ties of up to 422 g l−1 for sophorose lipids (Daniel et al., 1998),
112 g l−1 for rhamnose lipids (Giani et al., 1996), 110 g l−1 for spi-
culisporic acids (Tabuchi et al., 1977), 106 g l−1 for mannosylery-
thritol lipids (Morita et al., 2008) and 3,6 g l−1 for surfactin (Yeh
et al., 2005). These are rare exceptions within the typical amounts
produced by microorganisms, which usually do not exceed mil-
ligram amounts. The production level is strongly influenced by
non-favorable growth and production conditions due to a lack
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TABLE 11 | Actinobacterial strains identified to produce surface active compounds for which no structures have been elucidated.
Species Strain Compound References
Actinopolyspora sp. A18 n.d. GLP Doshi et al., 2010
Amycolatopsis tucumanensis DSM 45259 n.d. (bioemulsifier) Colin et al., 2013
Brachybacterium paraconglomeratum MSA21 n.d. GL (putative furan lipid/C12) Kiran et al., 2014
Brevibacterium aureum MSA13 n.d. LP (putative brevifactin/C18) Kiran et al., 2010c
Brevibacterium casei MSA19 n.d. GL (putative furan lipid/C18) Kiran et al., 2010a
Corynebacterium hydrocarboclastus n.a. n.d. polymer Zajic et al., 1997
Corynebacterium lepus n.a. n.d. LP Cooper et al., 1979a
Corynebacterium lepus n.a. n.d. GL Cooper et al., 1979a
Corynebacterium lepus n.a. p.d. (lipid, fatty acid, mycolic acid) Cooper et al., 1979b
Corynebacterium xerosis n.a. n.d. LP Margaritis et al., 1979
Dietzia maris WR-3 p.d. (putative wax-ester) Nakano et al., 2011
Dietzia sp. S-JS-1 n.d. LP Liu et al., 2009
Frankia sp. CpI1 n.d. GL Tunlid et al., 1989
Gordonia amarae SC1 n.d. (extracellular with high molecular weight) Iwahori et al., 2001
Gordonia rubripertincta DSM 46038 n.d. Pizzul et al., 2006
Gordonia sp. ADP n.d. Pizzul et al., 2006
Gordonia sp. BS29 n.d. GL Franzetti et al., 2010
Gordonia sp. JE-1058 n.d. (extracellular) Saeki et al., 2009
Kocuria marina BS-15 n.d. LP Sarafin et al., 2014
Leucobacter komagatae 183 p.d. LP Saimmai et al., 2012b
Microlunatus sp. NA2 n.d. Saimmai et al., 2012a
Nocardia erythropolis ATCC 4277 n.d. GL, PL Macdonald et al., 1981
Nocardioides sp. A-8 n.d. GL (putative Rhamnolipid) Vasileva-Tonkova and Gesheva, 2005
Nocardiopsis alba MSA10 n.d. LP Gandhimathi et al., 2009
Nocardiopsis lucentensis MSA04 n.d. GL (putative furan lipid/C9) Kiran et al., 2010b
Oerskovia xanthineolytica CIP 104849 p.d. GL (hexose, pentose C10–C18) Arino et al., 1998
Pseudonocardia sp. BSNC30C n.d. Ruggeri et al., 2009
Renibacterium salmoninarum 27BN n.d. GL (putative Rhamnolipid) Christova et al., 2004
Rhodococcus fascians A-3 n.d. GL (putative Rhamnolipid) Gesheva et al., 2010
Streptomyces sp. n.a. n.d. GL Khopade et al., 2011
GL, Glycolipid; GLP, Glycolipiopeptide; LP, Lipopeptide; PL, Phospholipid; n.a., information not available; n.d., not determined; p.d., partly determined.
of knowledge about the organism used and compound produced
when initially screening for novel surfactants or novel producer
strains.
With a few exceptions (Qian-Cutrone et al., 1999; Kügler et al.,
2014), the average minimum volume for successful structure elu-
cidation of an actinobacterial biosurfactant, is typically 20 l. Har-
vesting of the surfactants is type dependent and either whole cell
broth (intracellular or membrane associated surfactants) or cell
free supernatant is used as a starting point.
Glycolipids
A typical method for the extraction of surfactants from culture
broth or supernatant is the use of two phase extractions. In a first
step, if appropriate, non-polar solvents (e.g., n-hexane) are used
to remove residual hydrocarbons from the cultivation broth. If
extraction is carried out from whole cell broth or wet cell mass,
glycolipids are either captured by direct cell extraction or by cell
treatment (e.g., sonication) prior to the extraction.
In a second step, the surfactant is removed by repeated agi-
tation with a medium polar solvent or solvent mixture. Most
commonly, combinations of chloroform and methanol or polar
aprotic solvents such as ethyl acetate or methyl-tert-butyl ether
are used. A frequency solvent distribution for the extraction
of glycolipids from “rare” actinobacteria is shown in Figure 2,
comprising data of 47 two-phase extraction methods used to
enrich surfactants produced from either cell-free supernatant
or the culture broth. Depending on the chemical characteristics
of the glycolipid, an acidification step (pH2–pH3) with subse-
quent incubation (4◦C) prior to the extraction process could
result in enhanced product recoveries (Passeri et al., 1990; Kon-
ishi et al., 2014). Often, after dehumification, further washing
steps are applied, either of a hydrophilic (e.g., ultrapure water)
or a hydrophobic (e.g., n-hexane) nature. For the polymeric gly-
colipid lipoarabinomannan and related structures, a hot-phenol
water method is almost exclusively used (Sutcliffe, 2000).
The glycolipids produced, mainly present in mixtures of
different forms, need to be separated for structural analysis.
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FIGURE 2 | Frequency distribution of solvents used for the enrichment
of surfactants by two-phase extraction from the culture broth or cell
free supernatant of 47 “rare” actinobacteria.
This procedure is usually performed by combinations of chro-
matographic steps using either gradient columns or preparative
medium- and high pressure chromatography. In addition,
preparative planar chromatographies are reported as an addi-
tional purification step for the isolation of pure compounds
(Powalla et al., 1989; Pasciak et al., 2002, 2004). Rarely applied
is the use of absorbers within the cultivation process. The num-
ber one choice for chromatography is the use of hydrophobicity
affiliated separations with silicic acids as an absorbing material.
In approximately 80% of structure reports from “rare” actinobac-
teria, silicic acid is used with various elution gradients of non-
polar and polar solvents. Separated compounds are often further
purified by repetitive silica chromatography using different gradi-
ents or by subsequent (or preceding) steps with different column
material. Therefore, either reverse-phase C18 chromatography
or cellulose-based ionic interaction chromatography are widely
used.
Lipopeptides
The diversity of different peptide-based surface active com-
pounds produced by actinobacterial strains is much smaller than
that of reported glycolipids. Depending on the lipopeptide pro-
duced, two different approaches for the concentration of the
surfactants are used. Either the lipopeptide can be precipitated
from the liquid culture/supernatant by either using cold ace-
tone, methanol, salt concentrations, acidic environments, or a
direct extraction by medium polar solvents similar to those used
for glycolipids have been reported. Besides the chromatographic
purification steps used for glycolipids, gel filtration has been
successfully used as an additional step (Takizawa et al., 1995).
Structural Elucidation
Once a compound is purified to a sufficient extent, component
analysis, specific staining methods and mass spectroscopic exam-
inations are widely used to get a first hint about the type of sur-
factant produced. A more detailed schematic of the surfactant
can be deduced from mass spectroscopy fragmentation studies,
often revealing mass abundances of separated hydrophilic and
hydrophobic parts of the glycolipid. However, complete struc-
ture examinations (of complete compounds or hydrolyzed com-
ponents) rely on multi-dimensional nuclear magnetic resonance
spectroscopy.
Natural Habitats of
Biosurfactant-Producing Actinobacteria
With the exception of a few strains, the great majority of
surfactant-producing actinobacteria have been isolated from
three different environments. These are: (1) Hydrocarbon con-
taminated soils, (2) infections caused by the actinobacterium
itself, and (3) marine-derived samples. Obviously, this must not
reflect the distribution of surfactant-producing actinobacteria in
nature, but it is clear that there is a link between the type of
environment and the ability of actinobacteria to produce biosur-
factants and can be considered to be environmentally-driven.
Hydrocarbon Contaminated Soil
The formation of various actinobacterial surfactants is mainly
observed during growth in a range of different hydrophobic car-
bon sources such as n-paraffin, n-hexadecane or vegetable oils.
Occurrences of surfactant-producing microorganisms seems to
correlate to environments in which hydrophobic carbon sources
are present, no matter if these are oil contaminated or oil
enriched (Powalla et al., 1989; Arino et al., 1998; Christova et al.,
2004, 2014; Pizzul et al., 2006; Liu et al., 2009; Ruggeri et al.,
2009). Evoked by their hydrophobic cell wall due to incorpo-
ration and association of various lipoglycosides, actinobacteria
preferably grow in hydrophobic droplets that are dispersed in
the aqueous phase when cultured in cultivation devices. The sur-
factants produced facilitate the uptake of these difficult–to-access
carbon sources by dispersing it into small droplets that can easily
be pre-digested by extracellular enzymes.
Infections
A second feature of surfactants is the antimicrobial property
exhibited by most of these compounds. Endowed with nutri-
tional and growth advantages toward surrounding organisms,
surfactant producers can become rampant, and are often less
affected by substances present during its growth, e.g., antimi-
crobial drugs. They have been found in patients that suffer
from infections/diseases caused by human deficiency viruses
(Guérardel et al., 2003), patients with lung infections and infec-
tions of the oral cavity (Datta and Takayama, 1993; Sutcliffe, 1995;
Tanaka et al., 1997). In addition, biosurfactant-producing acti-
nobacterial strains have also been isolated from infected plant
tissue (Frahn et al., 1984).
Marine Habitat
Many actinobacteria are specialists in survival and native to a
wide range of extreme environments. Surfactant-producing gen-
era have been isolated from various marine-associated habitats
(Passeri et al., 1990; Khopade et al., 2011; Nakano et al., 2011).
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Several of these environments exhibit rather extreme condi-
tions, amongst which are deep sea sediments or hydrothermal
fields (Peng et al., 2008; Konishi et al., 2014; Wang et al., 2014),
ornithogenic exposed soil (Vasileva-Tonkova and Gesheva, 2005)
as well as actinobacteria isolated from sponges (Gandhimathi
et al., 2009; Kiran et al., 2010a,b,c, 2014) and hard corals (Osawa
et al., 2010). An antimicrobial effect of surfactants produced in
a highly procaryotic populated sponge tissue is apparent. How-
ever, the reason for the frequent occurrence of surfactant pro-
ducers within the other marine habitats, still remains to be
understood.
Summary and Conclusion
A wide range of unique and diverse surfactants produced by acti-
nobacteria have been reported. Various glycolipids, lipopeptides
and other surfactant types are produced by numerous species,
all belonging to the order Actinomycetales. Taking into account
the fact that only a minority of actinobacteria is culturable and
the given list of surfactant producing strains without structurally
elucidated compounds (Table 11), the sheer magnitude of acti-
nobacterial surfactants that still remain undetermined is evident.
The ability of actinobacteria to produce biosurfactants seems
to be influenced by their natural habitat. From the three main
sources of surfactant producing actinobacteria it can be con-
cluded that the compounds produced mainly serve for either
gaining access to hydrophobic carbon sources or as a bioactive
agent against competing strains.
In order to pave the way toward biotechnological applica-
tions of actinobacterial surfactants, emphasis should be placed
on (1) structural elucidation of described, but not identified bio-
surfactants, (2) the identification of novel actinobacterial sur-
factants by the implementation of next generation screening
methods; (3) the production of sufficient amounts of surfactants
for application based studies; and (4) production processes that
result in high yields and that would cut down on the production
costs.
(1) Actinobacterial strains with a surface active culture broth
or supernatant often are declared as “novel” biosurfactant
producing strains, without elucidation of the surface active
compound(s) produced and a list of producing strains is
given in this article whose surfactant structures remain to
be identified (Table 11). For a successful structural identifi-
cation of the compound, sufficient quantities of the isolated
surface active compound at an adequate purity is necessary
in order to apply the various analytical methods necessary.
This aspect was reviewed in the structural elucidation of
actinobacterial compounds section. Quite a few of the stud-
ies cited lacked sufficient strain information and further
research can only be ensured if the strains reported have
designated strain numbers and thus are available for other
researchers to pursue the production of these potentially
novel biosurfactants.
(2) Approaches for the identification of novel biosurfactants
mainly remain traditional by the detection of interesting
producing strains and subsequent isolation and charac-
terization of the compound produced. To further expand
the variety of actinobaterial surfactants, alternative screen-
ing methodologies that are already known to be used for
the detection of novel lead molecules in the pharmaceuti-
cal industry could be applied. Genome-based information
technology to reveal pathways that can be implemented
into artificial surfactant synthesis cascades are currently
being investigated. These attempts would allow for access
to both undetected and cryptic pathways present in acti-
nobacteria. By direct sequencing of metagenomic derived
DNA, enzyme information acquired could be expanded to
information gained from non-culturable and slow growing
species.
(3) Many of the surface active compounds produced by
actinobacteria potentially show interesting properties as
biotechnological products or additives. Often, as is the case
for many of the compounds summarized in this article, an
application based study is lacking. This is most probably
due to low availability of the product and can be traced
back to the use of low quantity producing strains. Focus
on a novel actinobacterial surfactant, along with progress in
the development toward novel biotechnology-based prod-
ucts, will only be made possible if enough substance for
initial studies on bioactivity or other interesting applica-
tions can be acquired. If an adequate amount of sub-
stance is not achievable by standard bioprocess engineering
attempts, metabolomic approaches and flux analysis could
lead the way. Furthermore, the identification of enzymes
involved in the synthesis and their genetic regulation can
give an important input into the improvement of fermenta-
tion processes. An implementation of the surfactant’s synthe-
sis through adequate heterologous production strains could
lead to higher quantities of the different surfactants pro-
duced. Potential applications of a novel compound is a guar-
antee of success in white biotechnology and negates the
efforts made with regards to its production, purification and
elucidation.
(4) Currently, comparatively high production costs combined
with low production yields restrict the development of com-
pounds as valuable products, and are mainly limited to high
purity applications, e.g., the drug industry. Several examples
in the past have shown that once a potential application for
a specific compound is foreseen, intensive research is set in
motion to facilitate production and purification processes,
cutting costs, enhancing yields and, although research often
lasts for decades, compounds might end in industrial scale
production and application.
One example of an actinobacterial surfactant that successfully
underwent the process from detection to application is the
antimicrobial agent daptomycin. It was initially produced semi-
synthetically in a three step procedure, but later a direct synthesis
of daptomycin was achieved by feeding toxic decanoic acid to a
carbon-limited production culture (Huber et al., 1988). Produc-
tion rates were further increased by 10–30% by using a mixture
of less toxic decanal and a solvent to solubilize the hydrophobic
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carbon feed (Bertetti et al., 2012). Mutagenesis approaches (Yu
et al., 2011; Li et al., 2013), genome shuﬄing (Yu et al., 2014) and
directed overexpression (Huang et al., 2012), have recently led to
further increases in production yields. Other examples of success
stories, are non-actinobacterial surfactants that have been pushed
to application: sophorolipids, mannosyl erythritol lipids and the
lipopeptide surfactin have found application in cosmetic indus-
tries (Fracchia et al., 2014). Sophorolipids are even applied in low
cost cleaning products.
Actinobacteria clearly represents a unique and vast untapped
resource for the discovery of novel and potentially useful bio-
surfactants. The surfactants produced by members of the class
Actinobacteria are a highly interesting group of products that
could be of great importance in the future in both the area of
basic research and application-oriented industrial research.
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